Bristol-Myers Squibb Co (NYSE: BMY)
DRUGS - Drug Manufacturers - MajorSector: Health Care
Stock price data as of 01/15/2021
Closing price: 66.54
Support price level: | $65.10 |
Resistance price level: | N/A |
Relative strength index (14-day RSI) | 83.1 |
Beta | 0.67 |
- BMY is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
- Up 6.5 percent, BMY is one of this week's biggest gainers.
- Volatility is forecast to fall over the next month.
- With RSI > 70, BMY is overbought. Odds slightly favor a short-term price reversal.
- Price broke above prior resistance level - a short-term bullish signal.
Low | High | Price as % of Range |
$46.40 | $67.43 | 96.4% |
200 day | 50 day | 20 day | 10 day |
$60.69 | $62.64 | $62.75 | $63.72 |
Historical (5 year) |
Last month | Current estimate | Next month forecast |
26.9% | 25.1% | 20.4% | 21.8% |
- 5.6% in the next week.
- 12.4% in the next month.
- 51.7% in the next year.
Company news for Bristol-Myers Squibb Co
Google Finance |
MarketWatch |
WSJ
Analysis for other Health Care stocks